NCT03492749View on ClinicalTrials.gov

Busulfan Concentration in Saliva and Plasma, and Its Relationship With Salivary Changes and Mucositis in the Digestive Tract of Patients Submitted to Hematopoietic Stem Cell Transplantation

CompletedOBSERVATIONAL
Enrollment

80

Participants

Timeline

Start Date

February 29, 2016

Primary Completion Date

February 29, 2020

Study Completion Date

August 31, 2020

Conditions
Bone Marrow Disease
Interventions
DIAGNOSTIC_TEST

Saliva monitoring

The first objective of this project is to verify the feasibility of using the analysis of salivary concentration of BU during individual adjustments of this drug in the period that precedes HSCT

All Listed Sponsors
lead

Hospital Israelita Albert Einstein

OTHER

NCT03492749 - Busulfan Concentration in Saliva and Plasma, and Its Relationship With Salivary Changes and Mucositis in the Digestive Tract of Patients Submitted to Hematopoietic Stem Cell Transplantation | Biotech Hunter | Biotech Hunter